UG Healthcare Corp. Ltd. AI Stock Analysis
Want to see SG:8K7 full AI Analyst Report?
UG Healthcare Corp. Ltd. (8K7) AI Stock Analysis
UG Healthcare Corp. Ltd.
(SGX:8K7)
The overall score is driven primarily by UG Healthcare's solid financial turnaround, marked by a return to profitability and positive cash generation. However, this fundamental strength is partially offset by a persistent long-term bearish technical trend and a moderate valuation without dividend support.
UG Healthcare Corp. Ltd. (8K7) vs. iShares MSCI Singapore ETF (EWS)
- Market Cap
- SGD 43.67M
- Dividend Yield
- ―
- Average Volume (3M)
- 171.96K
- Price to Earnings (P/E)
- 19.7
- Beta (1Y)
- 0.51
- Revenue Growth
- 4.69%
- EPS Growth
- ―
- Country
- Singapore
- Employees
- 743
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Instruments & Supplies
UG Healthcare Corp. Ltd. Business Overview & Revenue Model
Company Description
UG Healthcare Corporation Limited, an investment holding company established in Singapore in 1989, primarily engages in the manufacturing and worldwide distribution of disposable gloves. Its business is structured across three main segments: Latex Ex...
UG Healthcare Corp. Ltd. Financial Statement Overview
Summary
Financials highlight a post-boom turnaround with a return to top-line growth, profitability, and positive free cash flow. The low-leverage balance sheet provides stability, though profit margins remain thin.
Income Statement
65PositiveBalance Sheet
82Very PositiveCash Flow
75Positive| Breakdown | TTM | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 94.93M | 150.82M | 144.07M | 115.20M | 101.13M | 232.60M |
| Gross Profit | 3.43M | 42.87M | 34.74M | 25.87M | 1.45M | 84.39M |
| EBITDA | -21.20M | 11.41M | 2.47M | -3.94M | -23.97M | 53.37M |
| Net Income | -20.93M | 2.10M | -3.79M | -6.06M | -20.73M | 36.80M |
Balance Sheet | ||||||
| Total Assets | 215.39M | 240.52M | 232.35M | 226.45M | 230.00M | 288.04M |
| Cash, Cash Equivalents and Short-Term Investments | 45.13M | 27.41M | 23.29M | 28.00M | 61.74M | 100.22M |
| Total Debt | 28.46M | 40.52M | 47.36M | 43.72M | 31.13M | 17.98M |
| Total Liabilities | 44.08M | 70.75M | 76.03M | 65.17M | 48.81M | 52.98M |
| Stockholders Equity | 171.94M | 171.76M | 158.73M | 163.39M | 180.84M | 228.90M |
Cash Flow | ||||||
| Free Cash Flow | -36.98M | 14.97M | -8.11M | -20.71M | -47.17M | 31.63M |
| Operating Cash Flow | -34.35M | 17.59M | -4.78M | -18.16M | -39.14M | 53.95M |
| Investing Cash Flow | -2.63M | -2.62M | -3.21M | -22.73M | -8.03M | -21.19M |
| Financing Cash Flow | 4.62M | -11.20M | 3.24M | 8.36M | 8.70M | -973.00K |
UG Healthcare Corp. Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:8K7, the sentiment is Negative. The current price of 0.07 is below the 20-day moving average (MA) of 0.07, below the 50-day MA of 0.08, and below the 200-day MA of 0.08, indicating a bearish trend. The MACD of -0.00 indicates Positive momentum. The RSI at 43.86 is Neutral, neither overbought nor oversold. The STOCH value of 32.22 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SG:8K7.
UG Healthcare Corp. Ltd. Peers Comparison
Overall Rating
SG:OTX74Outperform
SG:8K764Neutral
Financial Indicators
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| SG:8K7 | UG Healthcare Corp. Ltd. | 0.07 | -0.03 | -30.93% | |
| SG:1J5 | Hyphens Pharma International Ltd. | 0.34 | 0.02 | 7.81% | |
| SG:505 | Asiamedic Limited | 0.02 | -0.00 | -11.11% | |
| SG:546 | Medtecs International Corporation Ltd. | 0.09 | -0.03 | -25.83% | |
| SG:MIJ | Alliance Healthcare Group Ltd. | 0.18 | 0.07 | 63.64% | |
| SG:OTX | Medinex Ltd. | 0.22 | -0.00 | -1.35% |
UG Healthcare Corp. Ltd. Corporate Events
UG Healthcare Shareholders Approve Key Annual General Meeting Resolutions
UG Healthcare Corporation held its annual general meeting, where shareholders received and adopted the audited financial statements for the financial year ended 30 June 2026. They also re-elected Lee Jun Linn as a director, approved S$120,000 in dire...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 29, 2026
